Kap 4 . Psychopharmacology and Neurotransmitters Flashcards

1
Q

Psychopharmacology

A

the study of the effects of drugs on the nervous system and behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Exogenous

A

produced outside the body

(rules out chemical messengers produced by the body, like neurotransmitters, neuromodulators, or hormones)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The definition of a drug

A

an exogenous chemical not necessary for normal cellular functioning that significantly alters the functions of certain cells of the body when taken in realtively low doses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

drug effects

A

the changes we can observe in an individual´s physiological processes and behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sites of action

A

are the locations where drug molecules bind with molecules located on or in cells of the body, to affect some biochemical processes of these cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The steps of Pharmacokinetics

A
  1. absorbed
  2. distributed within the body
  3. metabolized
  4. excreted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Peritoneal cavity

A

the space that surrounds the stomach, intestines, liver and other abdominal organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Intraperitoneal (IP) injection

A

injection through the abdominal wall
- not as rapid as IM
- commonly used in small laboratory animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Intramuscular (IM) injection

A
  • Directly into a large muscle (upper arm, thigh, buttocks)
  • more rapid than IP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Subcutaneous (SC) injection

A
  • beneath the skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Intracerebral administration

A

a procedure to study the effects of a drug in a specific region in the brain, where a researcher inject a very small amount of the drug directly into the brain

  • rapid druguse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Intracerebroventricular (ICV) adminitration

A
  • to achieve widespread distribution of a drug on the brain, you can pass the blood-brain barrier by injecting the drug into a cerebral ventrical
  • not used often on humans, but on certain types of infections, antibiotics might be delivered this way
  • rapid druguse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oral Administration

A
  • drugs though mouth –> digestive tract –> pass metabolism in the liver
  • some drugs will be destroyed by stomach acid and will be ineffective if taken orally
  • reach the site of action, slowly
    often used in therapeutic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sublingual administration

A

placing a drug beneath the tongue
- drug is absorbed into the bloodstream through the capillaries that supply the mucous membrane that lines the mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Topical administration

A

drugs absorbed through the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

insufflation

A

sniffing / snorting

17
Q

Affinity

A

the readiness with which two molecules join together - for the sites to which they attach

High affinity = effect low concentration
Low affinity = higher dose to get same effect

18
Q

dose-response curve

A

the best way to measure the effectiveness of a drug

se figur 4.4 s. 96

19
Q

Therapeutic index

A

a measure of a drug´s margin of safety

20
Q

Tolerance

A

when a drug is administered repeatedly its effects diminish

21
Q

Sensitization

A

when a drug is administered repeatedly its effects becomes more and more effective

22
Q

withdrawal symptoms

A

“opposite effect of the drug”

If an addicted drug uses stops taking the drug. For example heroin produces euphoria, relaxation, withdrawl produces dysphoria (feeling of anxious misery), agitation

23
Q

Receptor downregulation

A

“first compensensatory mechanism”
decrease receptor availability

The receptors become less sensitive the drug and their affinity for the drug decreases, or. the receptors decrease in number

24
Q

” second compensenstory mechanism”

A

involves the process that couples the receptors to ion channels in the membrane or the production of second messengers.

25
Q

Two spesific amino acid are the most common/important neurotransmitters in CNS

A

Glutamate and GABA

26
Q

4 major types of glutamate receptors

A

Ionotropic
1. NDMA receptor (important role in the cellular basis of learning and memory)
2. AMPA receptor ( –II – )
3. Kainate receptor

Metabotropic receptor
4. Metabotropic glutamate receptor. (presynaptic autoreceptors)

27
Q

glutamine excitotoxicity

A

produces when, too much glutamine stimulation in the synapse
- it damage neurons if prolonged and is belived to be involved in damage to the brain in stroke and amyotrophic lateral sclerosis

28
Q

Valium

A

diazepam

29
Q

Xanax

A

alprazolam

30
Q

Benzodiazepines

A

anxiolytics (anxiety-dissolving)

  • used to reduce symptoms of anxiety, reduce seizure activity, and produce muscle relaxation
31
Q

Botulinum toxin

A

Botox

32
Q

Why are does the drug effectivness vary?

A

They vary because they have different site of action and vary in their affinity for their binding sites

33
Q

Agonist

A

This are the substances that promote the activity of a neurotransmitter and thereby either stimulates the release or effect of a neurotransmitter, or it simulates the same effects. You can have direct and indirect agonists.

A direct agonist binds to the sites of a neurotransmitter, and thus kind of pretend to be a neurotransmitter with the same or comparable effect.

A indirect agonist binds to other sites, but thereby stimulates the original action process.

34
Q

Antagonist

A

Drugs that reduce the action of a neurotransmitter fall into this category. The direct antagonists bind to the same sites of action of a neurotransmitter, but thereby blocking the access for the real neurotransmitter, whereas an indirect antagonist uses other binding sites, but still
manages to block the original effect.

35
Q

Placebo

A

inactive substances, that trigger a placebo effect which is caused by changes in
motivation, expectation or classical conditioning.

“You might belive that there will be an effect so strongly, that you actually get an effect”

36
Q

Enzymatic Degradation

A

Enzymes (e.g., acetylcholinesterase) break down the neurotransmitter into inactive components.

37
Q

Precursor

A

en forløper er et stoff som fungerer som et utgangsmateriale eller byggestein for syntesen av en annen forbindelse, ofte et aktivt medikament. Forløpere omdannes kjemisk gjennom biologiske eller syntetiske prosesser for å produsere det ønskede stoffet.